HU170215B - - Google Patents
Info
- Publication number
- HU170215B HU170215B HUSA2816A HUSA002816A HU170215B HU 170215 B HU170215 B HU 170215B HU SA2816 A HUSA2816 A HU SA2816A HU SA002816 A HUSA002816 A HU SA002816A HU 170215 B HU170215 B HU 170215B
- Authority
- HU
- Hungary
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH931274 | 1974-07-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU170215B true HU170215B (en:Method) | 1977-04-28 |
Family
ID=4350618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUSA2816A HU170215B (en:Method) | 1974-07-05 | 1975-07-03 |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5132724A (en:Method) |
| AU (1) | AU8280175A (en:Method) |
| BE (1) | BE831042A (en:Method) |
| DE (1) | DE2528516A1 (en:Method) |
| ES (1) | ES439113A1 (en:Method) |
| FR (1) | FR2276832A1 (en:Method) |
| GB (1) | GB1518683A (en:Method) |
| HU (1) | HU170215B (en:Method) |
| IL (1) | IL47634A (en:Method) |
| NL (1) | NL7507798A (en:Method) |
| NZ (1) | NZ178011A (en:Method) |
| SE (1) | SE7507414L (en:Method) |
| YU (1) | YU170475A (en:Method) |
| ZA (1) | ZA754304B (en:Method) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54163810A (en) * | 1978-06-14 | 1979-12-26 | Mundipharma Ag | Gel composition for local coating |
| JPS56159310A (en) * | 1980-05-14 | 1981-12-08 | Showa Denko Kk | Preparation of monofilament having high strength and knot strength |
| FR2483235A1 (fr) * | 1980-05-28 | 1981-12-04 | Fabre Sa Pierre | Compositions a usage topique contenant des alcaloides de l'ergot de seigle et de vinca rosea destinees au traitement des hyperseborrhees |
| JPS59216825A (ja) * | 1983-05-23 | 1984-12-06 | Takeda Chem Ind Ltd | 経皮吸収外用製剤 |
| US5128376A (en) * | 1983-07-01 | 1992-07-07 | Nitto Denko Corporation | Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator |
| US4590190A (en) * | 1983-07-01 | 1986-05-20 | Nitto Electric Industrial Co., Ltd. | Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
| JPS6013720A (ja) * | 1983-07-01 | 1985-01-24 | Nitto Electric Ind Co Ltd | 生理的活性剤の吸収促進剤 |
| US4752612A (en) * | 1983-07-01 | 1988-06-21 | Nitto Electrical Industrial Co., Ltd. | Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
| US4751087A (en) * | 1985-04-19 | 1988-06-14 | Riker Laboratories, Inc. | Transdermal nitroglycerin delivery system |
| JPH0735331B2 (ja) * | 1986-01-16 | 1995-04-19 | 久光製薬株式会社 | 外用ゲル製剤 |
| JPH0735332B2 (ja) * | 1986-02-25 | 1995-04-19 | 久光製薬株式会社 | 外用クリ−ム製剤 |
| JPH0759519B2 (ja) * | 1987-02-23 | 1995-06-28 | 株式会社資生堂 | 経皮吸収促進剤及びこれを含有する皮膚外用製剤 |
| US4746515A (en) * | 1987-02-26 | 1988-05-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
| DE3710216A1 (de) * | 1987-03-27 | 1988-10-06 | Rentschler Arzneimittel | Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen |
| JPH0720866B2 (ja) * | 1987-05-15 | 1995-03-08 | 三生製薬株式会社 | エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤 |
| US5223261A (en) * | 1988-02-26 | 1993-06-29 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
| CH679119A5 (en:Method) * | 1988-05-13 | 1991-12-31 | Sandoz Ag | |
| GB2230444B (en) * | 1989-04-19 | 1993-12-08 | Ritchie Swanson John | Therapeutic compositions. |
| US5219877A (en) * | 1989-09-25 | 1993-06-15 | Bristol-Myers Squibb Company | Lauryl alcohol as skin penetration enhancer for topical imidazole agents |
| US5397771A (en) * | 1990-05-10 | 1995-03-14 | Bechgaard International Research And Development A/S | Pharmaceutical preparation |
| ATE164080T1 (de) * | 1990-05-10 | 1998-04-15 | Bechgaard Int Res | Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole |
| IL98747A0 (en) * | 1991-07-05 | 1992-07-15 | Yissum Res Dev Co | Ophthalmic compositions |
| US5681852A (en) * | 1993-11-12 | 1997-10-28 | The Procter & Gamble Company | Desquamation compositions |
| DE69429822T2 (de) * | 1993-11-12 | 2002-11-28 | The Procter & Gamble Company, Cincinnati | Abschuppende zusammensetzung von salicylsäure und zwitterionischen verbindungen |
| US5821237A (en) * | 1995-06-07 | 1998-10-13 | The Procter & Gamble Company | Compositions for visually improving skin |
| US6005135A (en) * | 1996-03-21 | 1999-12-21 | Exxon Chemical Patents Inc. | Water-borne polymeric vehicle for coating compositions containing an amine or ammonium salt of phenolic ester alcohols |
| US6096326A (en) * | 1997-08-15 | 2000-08-01 | Scandinavian-American Import/Export Corporation | Skin care compositions and use |
| US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
| ES2261190T3 (es) † | 1999-02-08 | 2006-11-16 | Alza Corporation | Vehiculos viscosos no acuosos estables de fase unica y formulaciones que utilizan dichos vehiculos. |
| US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| US8299025B2 (en) | 2005-02-03 | 2012-10-30 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof |
| WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
| EP2020990B1 (en) | 2006-05-30 | 2010-09-22 | Intarcia Therapeutics, Inc | Two-piece, internal-channel osmotic delivery system flow modulator |
| ES2422864T3 (es) | 2006-08-09 | 2013-09-16 | Intarcia Therapeutics, Inc | Sistemas de liberación osmótica y unidades de pistón |
| AU2008327436B2 (en) * | 2007-11-22 | 2013-09-05 | Medrx Co., Ltd. | External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| DK2240155T3 (da) | 2008-02-13 | 2012-09-17 | Intarcia Therapeutics Inc | Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler |
| CN104323981B (zh) | 2009-09-28 | 2019-03-12 | 精达制药公司 | 基本稳态药物递送的快速建立和/或终止 |
| JP2012020991A (ja) | 2010-06-16 | 2012-02-02 | Takasago Internatl Corp | 経皮吸収促進剤、及びこれを含有する皮膚外用製剤 |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| JP5820206B2 (ja) | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
| JP5820207B2 (ja) * | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| EP3395369A1 (en) | 2014-10-30 | 2018-10-31 | Asahi Kasei Kabushiki Kaisha | Transdermal absorption enhancer and transdermal absorption enhancement aid |
| EP4278996A3 (en) | 2015-06-03 | 2024-01-24 | i2o Therapeutics, Inc. | Implant placement systems |
| WO2017200943A1 (en) | 2016-05-16 | 2017-11-23 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| EP3565580B1 (en) | 2017-01-03 | 2024-03-06 | i2o Therapeutics, Inc. | Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel |
-
1975
- 1975-06-26 DE DE19752528516 patent/DE2528516A1/de active Pending
- 1975-06-27 SE SE7507414A patent/SE7507414L/xx unknown
- 1975-07-01 NL NL7507798A patent/NL7507798A/xx unknown
- 1975-07-02 YU YU01704/75A patent/YU170475A/xx unknown
- 1975-07-03 HU HUSA2816A patent/HU170215B/hu unknown
- 1975-07-03 FR FR7520946A patent/FR2276832A1/fr active Granted
- 1975-07-03 IL IL47634A patent/IL47634A/xx unknown
- 1975-07-03 NZ NZ178011A patent/NZ178011A/xx unknown
- 1975-07-03 ES ES439113A patent/ES439113A1/es not_active Expired
- 1975-07-04 GB GB28246/75A patent/GB1518683A/en not_active Expired
- 1975-07-04 ZA ZA754304A patent/ZA754304B/xx unknown
- 1975-07-04 BE BE158022A patent/BE831042A/xx unknown
- 1975-07-04 JP JP50082022A patent/JPS5132724A/ja active Pending
- 1975-07-07 AU AU82801/75A patent/AU8280175A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU8280175A (en) | 1977-01-13 |
| YU170475A (en) | 1984-02-29 |
| FR2276832B1 (en:Method) | 1978-10-06 |
| FR2276832A1 (fr) | 1976-01-30 |
| NZ178011A (en) | 1978-07-28 |
| SE7507414L (sv) | 1976-01-07 |
| JPS5132724A (en:Method) | 1976-03-19 |
| ES439113A1 (es) | 1977-10-16 |
| ZA754304B (en) | 1977-02-23 |
| IL47634A0 (en) | 1975-10-15 |
| DE2528516A1 (de) | 1976-01-22 |
| NL7507798A (nl) | 1976-01-07 |
| IL47634A (en) | 1978-07-31 |
| BE831042A (fr) | 1976-01-05 |
| GB1518683A (en) | 1978-07-19 |